Abstract
Patients with diffuse intrinsic pontine glioma (DIPG) face a grim prognosis with limited treatment options. Many patients will enroll on investigational trials though the role of chemotherapy or immunotherapy is unclear. Radiographic changes on conventional MRI are used to evaluate tumor response and progression, but are not predictive of outcome in these patients. More sensitive measures of tumor biology are needed to improve patient management. We evaluated changes in magnetic resonance spectroscopy (MRS) biomarkers in patients with DIPG. Thirty-eight patients were enrolled prospectively on an IRB-approved protocol, which included standard MRI, single voxel spectroscopy (SVS) and multi-slice multi-voxel spectroscopy (MRSI). Scans were performed at multiple time points during each patient’s clinical course, with a total of 142 scans. The prognostic values of Choline:N-acetylaspartate (Cho:NAA), Cho:Creatine (Cho:Cr) and the presence of lactate and lipids (+Lac/Lip) were evaluated. Cho:NAA and variance in Cho:NAA values among different voxels within a tumor were each predictive of shorter survival. This prospective study shows that MRS can be used to identify high-risk patients and monitor changes in tumor metabolism, which may reflect changes in tumor behavior.
Similar content being viewed by others
References
Central Brain Tumor Registry of the United States (CBTRUS) (2010) CBTRUS statistical report: primary and central nervous system tumors diagnosed in the United States in 2004–2006, Hindsdale, IL, pp 10–25
Ueoka DI, Nogueira J, Campos JC, Maranhao Filho P, Ferman S, Lima MA (2009) Brainstem gliomas-retrospective analysis of 86 patients. J Neurol Sci 281:20–23. doi:10.1016/j.jns.2009.03.009
Wolff JE, Classen CF, Wagner S, Kortmann RD, Palla SL, Pietsch T, Kuhl J, Gnekow A, Kramm CM (2008) Subpopulations of malignant gliomas in pediatric patients: analysis of the HIT-GBM database. J Neurooncol 87:155–164. doi:10.1007/s11060-007-9495-z
Shah NC, Ray A, Bartels U, Rutka J, Bouffet E, Drake J, Hawkins CE, Huang A (2008) Diffuse intrinsic brainstem tumors in neonates. Report of two cases. J Neurosurg Pediatr 1:382–385. doi:10.3171/PED/2008/1/5/382
Maria BL, Rehder K, Eskin TA, Hamed LM, Fennell EB, Quisling RG, Mickle JP, Marcus RB Jr, Drane WE, Mendenhall NP et al (1993) Brainstem glioma: I. Pathology, clinical features, and therapy. J Child Neurol 8:112–128
Hargrave D, Bartels U, Bouffet E (2006) Diffuse brainstem glioma in children: critical review of clinical trials. Lancet Oncol 7:241–248. doi:10.1016/S1470-2045(06)70615-5
Hargrave D, Chuang N, Bouffet E (2008) Conventional MRI cannot predict survival in childhood diffuse intrinsic pontine glioma. J Neurooncol 86:313–319. doi:10.1007/s11060-007-9473-5
Liu AK, Brandon J, Foreman NK, Fenton LZ (2009) Conventional MRI at presentation does not predict clinical response to radiation therapy in children with diffuse pontine glioma. Pediatr Radiol 39:1317–1320. doi:10.1007/s00247-009-1368-5
Kornreich L, Schwarz M, Karmazyn B, Cohen IJ, Shuper A, Michovitz S, Yaniv I, Fenig E, Horev G (2005) Role of MRI in the management of children with diffuse pontine tumors: a study of 15 patients and review of the literature. Pediatr Radiol 35:872–879. doi:10.1007/s00247-005-1502-y
Freeman CR, Farmer JP (1998) Pediatric brain stem gliomas: a review. Int J Radiat Oncol Biol Phys 40:265–271
Broniscer A, Gajjar A (2004) Supratentorial high-grade astrocytoma and diffuse brainstem glioma: two challenges for the pediatric oncologist. Oncologist 9:197–206
Kim CY, Kim SK, Phi JH, Lee MM, Kim IA, Kim IH, Wang KC, Jung HL, Lee MJ, Cho BK (2010) A prospective study of temozolomide plus thalidomide during and after radiation therapy for pediatric diffuse pontine gliomas: preliminary results of the Korean Society for pediatric neuro-oncology study. J Neurooncol. doi:10.1007/s11060-010-0157-1
Jalali R, Raut N, Arora B, Gupta T, Dutta D, Munshi A, Sarin R, Kurkure P (2010) Prospective evaluation of radiotherapy with concurrent and adjuvant temozolomide in children with newly diagnosed diffuse intrinsic pontine glioma. Int J Radiat Oncol Biol Phys 77:113–118. doi:10.1016/j.ijrobp.2009.04.031
Korones DN, Fisher PG, Kretschmar C, Zhou T, Chen Z, Kepner J, Freeman C (2008) Treatment of children with diffuse intrinsic brain stem glioma with radiotherapy, vincristine and oral VP-16: a Children’s Oncology Group phase II study. Pediatr Blood Cancer 50:227–230. doi:10.1002/pbc.21154
Massimino M, Spreafico F, Biassoni V, Simonetti F, Riva D, Trecate G, Giombini S, Poggi G, Pecori E, Pignoli E, Casanova M, Ferrari A, Meazza C, Luksch R, Terenziani M, Cefalo G, Podda M, Polastri D, Clerici CA, Fossati-Bellani F, Gandola L (2008) Diffuse pontine gliomas in children: changing strategies, changing results? A mono-institutional 20-year experience. J Neurooncol 87:355–361. doi:10.1007/s11060-008-9525-5
Frazier JL, Lee J, Thomale UW, Noggle JC, Cohen KJ, Jallo GI (2009) Treatment of diffuse intrinsic brainstem gliomas: failed approaches and future strategies. J Neurosurg Pediatr 3:259–269. doi:10.3171/2008.11.PEDS08281
Michalski A, Bouffet E, Taylor RE, Hargrave D, Walker D, Picton S, Robinson K, Pizer B, Bujkiewicz S (2010) The addition of high-dose tamoxifen to standard radiotherapy does not improve the survival of patients with diffuse intrinsic pontine glioma. J Neurooncol. doi:10.1007/s11060-010-0141-9
Broniscer A, Baker JN, Tagen M, Onar-Thomas A, Gilbertson RJ, Davidoff AM, Panandiker AP, Leung W, Chin TK, Stewart CF, Kocak M, Rowland C, Merchant TE, Kaste SC, Gajjar A (2010) Phase I study of vandetanib during and after radiotherapy in children with diffuse intrinsic pontine glioma. J Clin Oncol 28:4762–4768. doi:10.1200/JCO.2010.30.3545
Pincus DW, Richter EO, Yachnis AT, Bennett J, Bhatti MT, Smith A (2006) Brainstem stereotactic biopsy sampling in children. J Neurosurg 104:108–114. doi:10.3171/ped.2006.104.2.108
Perez-Gomez JL, Rodriguez-Alvarez CA, Marhx-Bracho A, Rueda-Franco F (2010) Stereotactic biopsy for brainstem tumors in pediatric patients. Childs Nerv Syst 26:29–34. doi:10.1007/s00381-009-1000-x
Zarghooni M, Bartels U, Lee E, Buczkowicz P, Morrison A, Huang A, Bouffet E, Hawkins C (2010) Whole-genome profiling of pediatric diffuse intrinsic pontine gliomas highlights platelet-derived growth factor receptor alpha and poly (ADP-ribose) polymerase as potential therapeutic targets. J Clin Oncol 28:1337–1344. doi:10.1200/JCO.2009.25.5463
Gilbertson RJ, Hill DA, Hernan R, Kocak M, Geyer R, Olson J, Gajjar A, Rush L, Hamilton RL, Finkelstein SD, Pollack IF (2003) ERBB1 is amplified and overexpressed in high-grade diffusely infiltrative pediatric brain stem glioma. Clin Cancer Res 9:3620–3624
Paugh BS, Qu C, Jones C, Liu Z, Adamowicz-Brice M, Zhang J, Bax DA, Coyle B, Barrow J, Hargrave D, Lowe J, Gajjar A, Zhao W, Broniscer A, Ellison DW, Grundy RG, Baker SJ (2010) Integrated molecular genetic profiling of pediatric high-grade gliomas reveals key differences with the adult disease. J Clin Oncol 28:3061–3068. doi:10.1200/JCO.2009.26.7252
Sanai N, Prados M (2010) Brainstem gliomas. In: Gupta N, Banerjee A, Haas-Kogan DA (eds) Pediatric CNS tumors, 1st edn. Springer, Berlin, pp 49–65
Peet AC, Lateef S, MacPherson L, Natarajan K, Sgouros S, Grundy RG (2007) Short echo time 1 H magnetic resonance spectroscopy of childhood brain tumours. Childs Nerv Syst 23:163–169. doi:10.1007/s00381-006-0206-4
Astrakas LG, Zurakowski D, Tzika AA, Zarifi MK, Anthony DC, De Girolami U, Tarbell NJ, Black PM (2004) Noninvasive magnetic resonance spectroscopic imaging biomarkers to predict the clinical grade of pediatric brain tumors. Clin Cancer Res 10:8220–8228. doi:10.1158/1078-0432.CCR-04-0603
Tzika AA, Astrakas LG, Zarifi MK, Zurakowski D, Poussaint TY, Goumnerova L, Tarbell NJ, Black PM (2004) Spectroscopic and perfusion magnetic resonance imaging predictors of progression in pediatric brain tumors. Cancer 100:1246–1256. doi:10.1002/cncr.20096
Warren KE, Frank JA, Black JL, Hill RS, Duyn JH, Aikin AA, Lewis BK, Adamson PC, Balis FM (2000) Proton magnetic resonance spectroscopic imaging in children with recurrent primary brain tumors. J Clin Oncol 18:1020–1026
Marcus KJ, Astrakas LG, Zurakowski D, Zarifi MK, Mintzopoulos D, Poussaint TY, Anthony DC, De Girolami U, Black PM, Tarbell NJ, Tzika AA (2007) Predicting survival of children with CNS tumors using proton magnetic resonance spectroscopic imaging biomarkers. Int J Oncol 30:651–657
Thakur SB, Karimi S, Dunkel IJ, Koutcher JA, Huang W (2006) Longitudinal MR spectroscopic imaging of pediatric diffuse pontine tumors to assess tumor aggression and progression. AJNR Am J Neuroradiol 27:806–809
Panigrahy A, Nelson MD Jr, Finlay JL, Sposto R, Krieger MD, Gilles FH, Bluml S (2008) Metabolism of diffuse intrinsic brainstem gliomas in children. Neuro Oncol 10:32–44. doi:10.1215/15228517-2007-042
Laprie A, Pirzkall A, Haas-Kogan DA, Cha S, Banerjee A, Le TP, Lu Y, Nelson S, McKnight TR (2005) Longitudinal multivoxel MR spectroscopy study of pediatric diffuse brainstem gliomas treated with radiotherapy. Int J Radiat Oncol Biol Phys 62:20–31. doi:10.1016/j.ijrobp.2004.09.027
Duyn JH, Gillen J, Sobering G, van Zijl PC, Moonen CT (1993) Multisection proton MR spectroscopic imaging of the brain. Radiology 188:277–282
Jacobs MA, Horska A, van Zijl PC, Barker PB (2001) Quantitative proton MR spectroscopic imaging of normal human cerebellum and brain stem. Magn Reson Med 46:699–705
Tedeschi G, Bertolino A, Campbell G, Barnett AS, Duyn JH, Jacob PK, Moonen CT, Alger JR, Di Chiro G (1996) Reproducibility of proton MR spectroscopic imaging findings. AJNR Am J Neuroradiol 17:1871–1879
Klein JP, Moeschberger ML (2003) Survival analysis techniques for censored and truncated data. Springer Science + Business Media Inc, New York, NY
McKnight TR, Lamborn KR, Love TD, Berger MS, Chang S, Dillon WP, Bollen A, Nelson SJ (2007) Correlation of magnetic resonance spectroscopic and growth characteristics within Grades II and III gliomas. J Neurosurg 106:660–666. doi:10.3171/jns.2007.106.4.660
Law M, Yang S, Wang H, Babb JS, Johnson G, Cha S, Knopp EA, Zagzag D (2003) Glioma grading: sensitivity, specificity, and predictive values of perfusion MR imaging and proton MR spectroscopic imaging compared with conventional MR imaging. AJNR Am J Neuroradiol 24:1989–1998
Ng WH, Lim T (2008) Targeting regions with highest lipid content on MR spectroscopy may improve diagnostic yield in stereotactic biopsy. J Clin Neurosci 15:502–506. doi:10.1016/j.jocn.2007.04.005
Balmaceda C, Critchell D, Mao X, Cheung K, Pannullo S, DeLaPaz RL, Shungu DC (2006) Multisection 1H magnetic resonance spectroscopic imaging assessment of glioma response to chemotherapy. J Neurooncol 76:185–191. doi:10.1007/s11060-005-5261-2
Hayward RM, Patronas N, Baker EH, Vezina G, Albert PS, Warren KE (2008) Inter-observer variability in the measurement of diffuse intrinsic pontine gliomas. J Neurooncol 90:57–61. doi:10.1007/s11060-008-9631-4
Yang I, Huh NG, Smith ZA, Han SJ, Parsa AT (2010) Distinguishing glioma recurrence from treatment effect after radiochemotherapy and immunotherapy. Neurosurg Clin N Am 21:181–186. doi:10.1016/J.Nec.2009.08.003
Nelson MD Jr, Soni D, Baram TZ (1994) Necrosis in pontine gliomas: radiation induced or natural history? Radiology 191:279–282
Liu AK, Macy ME, Foreman NK (2009) Bevacizumab as therapy for radiation necrosis in four children with pontine gliomas. Int J Radiat Oncol Biol Phys 75:1148–1154. doi:10.1016/j.ijrobp.2008.12.032
Castillo M, Kwock L (1998) Proton MR spectroscopy of common brain tumors. Neuroimaging Clin N Am 8:733–752
Tzika AA, Zarifi MK, Goumnerova L, Astrakas LG, Zurakowski D, Young-Poussaint T, Anthony DC, Scott RM, Black PM (2002) Neuroimaging in pediatric brain tumors: Gd-DTPA-enhanced, hemodynamic, and diffusion MR imaging compared with MR spectroscopic imaging. AJNR Am J Neuroradiol 23:322–333
Nelson SJ (2003) Multivoxel magnetic resonance spectroscopy of brain tumors. Mol Cancer Ther 2:497–507
Senft C, Hattingen E, Pilatus U, Franz K, Schanzer A, Lanfermann H, Seifert V, Gasser T (2009) Diagnostic value of proton magnetic resonance spectroscopy in the noninvasive grading of solid gliomas: comparison of maximum and mean choline values. Neurosurgery 65:908–913. doi:10.1227/01.NEU.0000356982.82378.BA (discussion 913)
Wagner M, Nafe R, Jurcoane A, Pilatus U, Franz K, Rieger J, Steinbach JP, Hattingen E (2010) Heterogeneity in malignant gliomas: a magnetic resonance analysis of spatial distribution of metabolite changes and regional blood volume. J Neurooncol. doi:10.1007/s11060-010-0443-y
Chen CY, Lirng JF, Chan WP, Fang CL (2004) Proton magnetic resonance spectroscopy-guided biopsy for cerebral glial tumors. J Formos Med Assoc 103:448–458
Lupo JM, Cha S, Chang SM, Nelson SJ (2007) Analysis of metabolic indices in regions of abnormal perfusion in patients with high-grade glioma. AJNR Am J Neuroradiol 28:1455–1461. doi:10.3174/ajnr.A0586
Krieger MD, Bluml S, McComb JG (2003) Magnetic resonance spectroscopy of atypical diffuse pontine masses. Neurosurg Focus 15:E5
Barker PB, Lin DDM (2006) In vivo proton MR spectroscopy of the human brain. Prog Nucl Magn Reson Spectrosc 49:99–128
de Graff R (2007) In vivo NMR spectroscopy: principles and techniques. Wiley, West Sussex
Mascalchi M, Brugnoli R, Guerrini L, Belli G, Nistri M, Politi LS, Gavazzi C, Lolli F, Argenti G, Villari N (2002) Single-voxel long TE 1H-MR spectroscopy of the normal brainstem and cerebellum. J Magn Reson Imaging 16:532–537. doi:10.1002/jmri.10189
McLean MA, Cross JJ (2009) Magnetic resonance spectroscopy: principles and applications in neurosurgery. Br J Neurosurg 23:5–13. doi:10.1080/02688690802491673
Acknowledgments
The authors thank Dr. Alan Barnett and Dr. Jan Willem van der Veen for their contributions towards the MRSI acquisition and data analysis. This work was presented in part at the ASNR 47th Annual Meeting, Vancouver 2009. Research was supported in part by the Intramural Research Program of the National Institutes of Health, National Cancer Institute, Center for Cancer Research. The views expressed in this article are those of the authors and do not reflect the official policy of the National Institutes of Health, Department of Army, Department of Defense, or U.S. Government.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Steffen-Smith, E.A., Shih, J.H., Hipp, S.J. et al. Proton magnetic resonance spectroscopy predicts survival in children with diffuse intrinsic pontine glioma. J Neurooncol 105, 365–373 (2011). https://doi.org/10.1007/s11060-011-0601-x
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s11060-011-0601-x